25 au 28 octobre 2013
Deux chercheurs travaillant sur Crigler-Najjar, Federico Mingozzi (Genethon) et Cécilia Abarrategui (Nantes), présenteront leurs travaux.
- Federico Mingozzi, Généthon, Evry ; University Pierre and Marie Curie, Paris :
- -Progress and challenges of in vivo gene transfer with AAV vectors
- -Immune responses to AAV vectors in human trials
- Cecilia Abarrategui Pontes, UMR 1064 University Hospital, Nantes
- -In vivo gene repair of inherited liver diseases using artiἀcial endonucleases : application to Crigler Najjar disease